While tirzepatide remained on the shortage list, compounding pharmacies had broader legal authority to produce copies of the drug
Long-term Risks : Persistent high blood sugar can lead to complications such as cardiovascular diseases and nerve damage
Bajaj JS, Hassanein TI, Pyrsopoulos NT, et al
Enhanced appetite suppression pathways
Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials FDA warns about unapproved GLP-1 drugs online, calls for accessible trials The FDA has issued warnings about unapproved GLP-1 drugs circulating online - counterfeit, compounded, or mislabeled as research use only. When access to legitimate GLP-1 clinical trials is limited - by geography, logistics, or site capacity - progress slows
Regulatory considerations and quality standards for novel peptide therapeutics in obesity treatment